ASCO Session Explores Immune Responses Evoked by Mutation-Prone Endometrial, Ovarian Cancer Subtypes | GenomeWeb

Note: This article has been updated to clarify the nature of the tumor infiltrating lymphocytes elevated in the BRCA1/2-mutated ovarian tumors.

CHICAGO (GenomeWeb) – Researchers have started tracking immune responses to different genomically defined cancer subtypes in an attempt to find those most apt to respond to immunotherapy-based treatment approaches, attendees heard here this week at the American Society of Clinical Oncology annual meeting.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Sponsored by
Agilent Technologies

This webinar will provide specific use cases from a molecular pathology lab demonstrating how an automated bioinformatics pipeline can improve somatic variant assessment and reporting.